How to Improve the Clinical Development Paradigm and its Division into Phases I, II and III
Therapie, 66 4 (2011) 331-334
Published online: 2011-08-19
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Investigación clínica en la era de la inmunoterapia y la genómica
Briegel De las Salas, Natalia Sánchez, Liliana Gutiérrez, Stefany Pérez, Vanessa Mercado, Paola Becerra, Adriana Aya, Edwin Pulido, Heidy Trujillo, Christian Rolfo, Luis Raez, Oscar Arrieta, Alejandro Ruíz-Patiño and Andrés F. CardonaMedicina 46 (2) 372 (2024)
https://doi.org/10.56050/01205498.2371
How to conduct well-designed clinical research
Da Jung Kim, Song Yi Kil, Jongwon Son and Ho Sup LeeKosin Medical Journal 37 (3) 187 (2022)
https://doi.org/10.7180/kmj.22.122
Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antibacterial Agents: A Review
Anselm Jorda and Markus ZeitlingerClinical Pharmacokinetics 59 (9) 1071 (2020)
https://doi.org/10.1007/s40262-020-00892-0
What is pharmacoepidemiology? Definition, methods, interest and clinical applications
Jean-Louis Montastruc, Justine Benevent, François Montastruc, Haleh Bagheri, Fabien Despas, Maryse Lapeyre-Mestre and Agnès SommetTherapies 74 (2) 169 (2019)
https://doi.org/10.1016/j.therap.2018.08.001
Qu’est-ce que la pharmacoépidémiologie?
Jean-Louis Montastruc, Agnès Sommet, François Montastruc, Guillaume Moulis, Haleh Bagheri, Christine Damasemichel and et Maryse Lapeyre-MestreBulletin de l'Académie Nationale de Médecine 199 (2-3) 263 (2015)
https://doi.org/10.1016/S0001-4079(19)30970-7